title: Immobilization of Chacoan peccaries (Catagonus wagneri) using medetomidine, Telazol, and ketamine.
abstract: A combination of medetomidine, Telazol, and ketamine hydrochloride was used to immobilize captive Chacoan peccaries (Catagonus wagneri) for translocation within Paraguay during August-October 2002. Animals were darted in enclosed areas of varying size. The average dose used was 32.5+/-7.2 microg/kg of medetomidine, 0.63+/-0.2 mg/kg of Telazol, and 3.9+/-0.65 mg/kg of ketamine. First effects were noted at 4.3+/-2.1 min, and ability to handle the animals was achieved by 12.6+/-3.7 min. Heart and respiratory rates declined and oxygen saturation increased during anesthesia. Muscle relaxation was good. Atipamezole was used to antagonize the medetomidine, although recoveries were still slow. This drug combination provided adequate immobilization of Chacoan peccaries; however, this protocol would not be considered to be reversible, and confinement during recovery is recommended.
authors.affiliation: Zoological Society of San Diego, P.O. Box 120551, San Diego, California 92112, USA. msutherlan@sandiegozoo.org
authors.forename: Meg
authors.initials: M
authors.lastname: Sutherland-Smith
authors.forename: Juan Manuel
authors.initials: JM
authors.lastname: Campos
authors.forename: Carrie
authors.initials: C
authors.lastname: Cramer
authors.forename: Cindy
authors.initials: C
authors.lastname: Thorstadt
authors.forename: William
authors.initials: W
authors.lastname: Toone
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Morris
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000778:Anesthetics, Dissociative / Q000008:administration & dosage*; D000818:Animals; D001188:Artiodactyla / Q000502:physiology*; D004338:Drug Combinations; D006339:Heart Rate / Q000187:drug effects; D006993:Hypnotics and Sedatives / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D007093:Imidazoles / Q000494:pharmacology; D007103:Immobilization / Q000379:methods / Q000662:veterinary*; D007649:Ketamine / Q000008:administration & dosage; D020926:Medetomidine / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D010092:Oximetry / Q000662:veterinary; D010100:Oxygen / Q000097:blood; D012119:Respiration / Q000187:drug effects; D013992:Tiletamine / Q000008:administration & dosage; D013997:Time Factors; D015041:Zolazepam / Q000008:administration & dosage
chemical_list: D000317:Adrenergic alpha-Antagonists; D000778:Anesthetics, Dissociative; D004338:Drug Combinations; D006993:Hypnotics and Sedatives; D007093:Imidazoles; C006131:tiletamine, zolazepam drug combination; C050701:atipamezole; D013992:Tiletamine; D007649:Ketamine; D015041:Zolazepam; D020926:Medetomidine; D010100:Oxygen